Bioxtract Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Bioxtract General Information

Description

Developer and manufacturer of innovative food supplements or ingredients intended to offer ready-to-use finished dosages of supplements for pharmaceutical and food supplement industries and export markets. The company's food supplements are made from natural active ingredients, based on bibliographical pre-clinical and clinical evidence, enabling medical professionals to treat a particular target using a specific formulation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Parc Scientifique Créalys
  • Rue Guillaume Fouquet 30
  • 5032 Isnes
  • Belgium
+32 081
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Parc Scientifique Créalys
  • Rue Guillaume Fouquet 30
  • 5032 Isnes
  • Belgium
+32 081

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioxtract Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Feb-2021 Completed Generating Revenue
2. Early Stage VC 17-Feb-2004 Completed Generating Revenue
1. University Spin-Out 01-Jan-2003 Completed
To view Bioxtract’s complete valuation and funding history, request access »

Bioxtract Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Category B
Category B
Category A 4,130 $31.56 $31.56 1x $31.56 42.36%
To view Bioxtract’s complete cap table history, request access »

Bioxtract Patents

Bioxtract Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2229940-A1 Pharmaceutical composition presenting anti-inflammatory and anti-histaminic properties Active 20-Mar-2009
EP-2229940-B1 Pharmaceutical composition presenting anti-inflammatory and anti-histaminic properties Inactive 20-Mar-2009
AU-2010224811-A1 Pharmaceutical composition presenting anti-inflammatory properties Active 20-Mar-2009
AU-2010224811-B2 Pharmaceutical composition presenting anti-inflammatory properties Inactive 20-Mar-2009
EP-2408442-A1 Pharmaceutical composition presenting anti-inflammatory properties Active 20-Mar-2009 A61K9/4858
To view Bioxtract’s complete patent history, request access »

Bioxtract Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioxtract Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Liege University
To view Bioxtract’s complete investors history, request access »

Bioxtract FAQs

  • When was Bioxtract founded?

    Bioxtract was founded in 2003.

  • Where is Bioxtract headquartered?

    Bioxtract is headquartered in Isnes, Belgium.

  • What is the size of Bioxtract?

    Bioxtract has 3 total employees.

  • What industry is Bioxtract in?

    Bioxtract’s primary industry is Biotechnology.

  • Is Bioxtract a private or public company?

    Bioxtract is a Private company.

  • What is Bioxtract’s current revenue?

    The current revenue for Bioxtract is .

  • How much funding has Bioxtract raised over time?

    Bioxtract has raised $694K.

  • Who are Bioxtract’s investors?

    University of Liege has invested in Bioxtract.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process